Magnetic Tides

Country:
USA
Founding year:
2019

Magnetic Tides is developing kTMP, a non-invasive brain stimulation platform based on UC Berkeley research. The company sits within therapeutic neuromodulation, with an initial clinical focus on chronic stroke motor recovery and broader applicability across neurological and psychiatric conditions. Its work is centered on improving arm and hand function in patients with long-term motor impairment after stroke.

kTMP, or kilohertz transcranial magnetic perturbation, delivers frequency-specific electric fields through a magnetic stimulation system. The approach is designed to provide spatial targeting and adjustable stimulation parameters, while modulating cortical excitability in circuits relevant to recovery. Magnetic Tides describes the technology as a distinct non-invasive stimulation method that draws on elements of magnetic and electrical brain stimulation.

Magnetic Tides targets patients with chronic stroke through clinical development pathways, with FDA Breakthrough Device Designation reported for improving arm and hand function. The company is best understood as an investigational neuromodulation developer building a new non-invasive stimulation modality for motor recovery and related brain-disorder applications.

Neuromodulation
Therapeutics
Experimental

Neurofounders Insights

Modality:
TMS
Form Factor:
External device
Interface Depth:
Non-invasive
Indication:
Stroke
Target user:
Patients
Regulatory stage:
Investigational

Non-dilutive

Magnetic Tides sits in the non-invasive brain stimulation segment, with kTMP positioned as a technical extension of the TMS and electrical-stimulation design space. Its relevance comes from targeting chronic stroke motor recovery with a stimulation approach built around frequency-specific, spatially targeted cortical modulation.

Related companies

Articles featuring

Magnetic Tides

No articles yet!

Press releases

No press releases published yet.